 Colleen McIlvennan
Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 59 | 2024 | 554 | 11.930 |
Why?
| | Heart Failure | 82 | 2025 | 2059 | 9.370 |
Why?
| | Caregivers | 26 | 2024 | 905 | 4.680 |
Why?
| | Terminal Care | 10 | 2022 | 246 | 2.050 |
Why?
| | Decision Making | 15 | 2023 | 946 | 2.040 |
Why?
| | Palliative Care | 10 | 2024 | 815 | 1.540 |
Why?
| | Heart Transplantation | 8 | 2024 | 709 | 1.530 |
Why?
| | Quality of Life | 22 | 2024 | 2954 | 1.470 |
Why?
| | Ventricular Function, Left | 4 | 2020 | 503 | 1.100 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2023 | 362 | 1.020 |
Why?
| | Choice Behavior | 2 | 2020 | 173 | 0.980 |
Why?
| | Delivery of Health Care | 4 | 2023 | 961 | 0.940 |
Why?
| | Cardiology | 2 | 2019 | 277 | 0.940 |
Why?
| | Patient Care Team | 5 | 2024 | 642 | 0.930 |
Why?
| | Health Knowledge, Attitudes, Practice | 7 | 2024 | 1369 | 0.920 |
Why?
| | Humans | 102 | 2025 | 139062 | 0.850 |
Why?
| | Thrombosis | 3 | 2021 | 383 | 0.840 |
Why?
| | Heart Injuries | 1 | 2023 | 38 | 0.780 |
Why?
| | Physician-Patient Relations | 4 | 2024 | 582 | 0.770 |
Why?
| | Stress, Psychological | 3 | 2021 | 1124 | 0.770 |
Why?
| | Patient Participation | 7 | 2025 | 426 | 0.750 |
Why?
| | Emotions | 6 | 2023 | 565 | 0.750 |
Why?
| | Registries | 6 | 2024 | 2054 | 0.740 |
Why?
| | Middle Aged | 41 | 2025 | 33864 | 0.700 |
Why?
| | Patients | 3 | 2023 | 180 | 0.690 |
Why?
| | Substance Abuse Detection | 2 | 2025 | 100 | 0.670 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 156 | 0.650 |
Why?
| | Patient Preference | 6 | 2024 | 197 | 0.650 |
Why?
| | Palliative Medicine | 2 | 2017 | 17 | 0.650 |
Why?
| | Health Literacy | 3 | 2024 | 170 | 0.640 |
Why?
| | Delirium | 1 | 2021 | 96 | 0.630 |
Why?
| | Patient Readmission | 2 | 2015 | 706 | 0.610 |
Why?
| | Biomedical Research | 3 | 2020 | 699 | 0.590 |
Why?
| | Attitude to Death | 2 | 2016 | 68 | 0.580 |
Why?
| | Aged | 32 | 2025 | 24236 | 0.570 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 375 | 0.570 |
Why?
| | Risk Assessment | 6 | 2020 | 3469 | 0.570 |
Why?
| | Coronavirus Infections | 2 | 2020 | 373 | 0.570 |
Why?
| | Betacoronavirus | 2 | 2020 | 275 | 0.560 |
Why?
| | Male | 49 | 2025 | 68324 | 0.560 |
Why?
| | Qualitative Research | 9 | 2024 | 1445 | 0.550 |
Why?
| | Patient Acceptance of Health Care | 3 | 2020 | 854 | 0.540 |
Why?
| | Hospice Care | 3 | 2016 | 201 | 0.530 |
Why?
| | Decision Making, Computer-Assisted | 1 | 2017 | 17 | 0.530 |
Why?
| | Female | 49 | 2025 | 74074 | 0.530 |
Why?
| | Surveys and Questionnaires | 9 | 2024 | 5892 | 0.520 |
Why?
| | Caliciviridae Infections | 1 | 2016 | 20 | 0.510 |
Why?
| | Hospital Records | 1 | 2016 | 10 | 0.510 |
Why?
| | Mexiletine | 1 | 2016 | 6 | 0.500 |
Why?
| | Amphetamine | 1 | 2016 | 37 | 0.500 |
Why?
| | Hospitalization | 5 | 2024 | 2223 | 0.490 |
Why?
| | Quality Improvement | 4 | 2021 | 1202 | 0.490 |
Why?
| | Cryosurgery | 1 | 2016 | 46 | 0.480 |
Why?
| | Physicians | 4 | 2020 | 929 | 0.470 |
Why?
| | Bereavement | 1 | 2016 | 56 | 0.470 |
Why?
| | Myocardial Infarction | 1 | 2023 | 1069 | 0.470 |
Why?
| | Adaptation, Psychological | 9 | 2024 | 672 | 0.470 |
Why?
| | Clinical Decision-Making | 2 | 2024 | 335 | 0.460 |
Why?
| | Transplant Recipients | 1 | 2016 | 189 | 0.440 |
Why?
| | Drug Monitoring | 1 | 2016 | 211 | 0.440 |
Why?
| | Partial Thromboplastin Time | 1 | 2014 | 54 | 0.440 |
Why?
| | Patient-Centered Care | 4 | 2021 | 545 | 0.440 |
Why?
| | Heart Diseases | 2 | 2017 | 336 | 0.440 |
Why?
| | Tachycardia, Ventricular | 1 | 2016 | 170 | 0.430 |
Why?
| | Adult | 29 | 2025 | 38389 | 0.430 |
Why?
| | Heart Ventricles | 4 | 2021 | 741 | 0.430 |
Why?
| | Depression | 2 | 2021 | 1467 | 0.420 |
Why?
| | Treatment Outcome | 13 | 2024 | 10961 | 0.420 |
Why?
| | Stroke Volume | 4 | 2023 | 580 | 0.410 |
Why?
| | Advance Care Planning | 2 | 2017 | 221 | 0.410 |
Why?
| | Decision Support Techniques | 4 | 2020 | 425 | 0.410 |
Why?
| | Research Design | 1 | 2019 | 1121 | 0.390 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1516 | 0.390 |
Why?
| | Blood Coagulation | 1 | 2014 | 265 | 0.380 |
Why?
| | Substance-Related Disorders | 2 | 2025 | 1083 | 0.380 |
Why?
| | United States | 18 | 2025 | 15065 | 0.380 |
Why?
| | Attitude to Health | 1 | 2016 | 458 | 0.380 |
Why?
| | Pandemics | 2 | 2020 | 1650 | 0.380 |
Why?
| | Informed Consent | 1 | 2014 | 188 | 0.380 |
Why?
| | Interviews as Topic | 4 | 2024 | 806 | 0.370 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1310 | 0.360 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2057 | 0.360 |
Why?
| | Anticoagulants | 2 | 2021 | 669 | 0.340 |
Why?
| | American Heart Association | 4 | 2024 | 284 | 0.340 |
Why?
| | Activities of Daily Living | 1 | 2014 | 419 | 0.330 |
Why?
| | Health Personnel | 2 | 2022 | 726 | 0.310 |
Why?
| | Program Development | 2 | 2023 | 362 | 0.290 |
Why?
| | Patient Reported Outcome Measures | 4 | 2024 | 408 | 0.280 |
Why?
| | Social Support | 3 | 2024 | 628 | 0.270 |
Why?
| | Patient Education as Topic | 3 | 2018 | 763 | 0.270 |
Why?
| | Risk Factors | 9 | 2021 | 10426 | 0.250 |
Why?
| | Withholding Treatment | 2 | 2016 | 78 | 0.240 |
Why?
| | Mental Health | 2 | 2023 | 740 | 0.240 |
Why?
| | Cost of Illness | 2 | 2020 | 308 | 0.230 |
Why?
| | Communication | 4 | 2024 | 932 | 0.230 |
Why?
| | Data Collection | 2 | 2019 | 663 | 0.220 |
Why?
| | Health Services Needs and Demand | 2 | 2024 | 279 | 0.220 |
Why?
| | Troponin | 1 | 2023 | 50 | 0.200 |
Why?
| | Cardiovascular Agents | 1 | 2024 | 155 | 0.190 |
Why?
| | Quality Assurance, Health Care | 1 | 2024 | 329 | 0.190 |
Why?
| | Hospital Mortality | 2 | 2016 | 919 | 0.170 |
Why?
| | Frailty | 1 | 2024 | 172 | 0.170 |
Why?
| | Trust | 1 | 2022 | 143 | 0.170 |
Why?
| | Guideline Adherence | 1 | 2025 | 557 | 0.170 |
Why?
| | Survival Rate | 3 | 2024 | 1935 | 0.170 |
Why?
| | Home Nursing | 1 | 2020 | 25 | 0.160 |
Why?
| | Retrospective Studies | 12 | 2025 | 15922 | 0.160 |
Why?
| | Self Report | 1 | 2024 | 840 | 0.160 |
Why?
| | BK Virus | 1 | 2019 | 17 | 0.160 |
Why?
| | Thoracentesis | 1 | 2019 | 5 | 0.160 |
Why?
| | Aged, 80 and over | 5 | 2024 | 7698 | 0.150 |
Why?
| | Psychosocial Support Systems | 1 | 2019 | 12 | 0.150 |
Why?
| | Medicare | 2 | 2015 | 790 | 0.150 |
Why?
| | Data Accuracy | 1 | 2019 | 65 | 0.150 |
Why?
| | Family | 1 | 2023 | 677 | 0.150 |
Why?
| | Ethics Committees, Research | 1 | 2019 | 42 | 0.150 |
Why?
| | Prospective Studies | 4 | 2024 | 7660 | 0.150 |
Why?
| | Motion Pictures | 1 | 2019 | 19 | 0.150 |
Why?
| | Home Infusion Therapy | 1 | 2018 | 4 | 0.150 |
Why?
| | Viremia | 1 | 2019 | 152 | 0.150 |
Why?
| | Biomarkers | 2 | 2023 | 4115 | 0.150 |
Why?
| | Device Removal | 1 | 2020 | 140 | 0.150 |
Why?
| | Research Support as Topic | 1 | 2019 | 118 | 0.140 |
Why?
| | Warfarin | 2 | 2021 | 155 | 0.140 |
Why?
| | Nurse Practitioners | 2 | 2019 | 137 | 0.140 |
Why?
| | Outpatients | 2 | 2023 | 416 | 0.140 |
Why?
| | Chronic Disease | 3 | 2022 | 1802 | 0.140 |
Why?
| | Immunocompromised Host | 1 | 2019 | 208 | 0.140 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 95 | 0.140 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 903 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2019 | 163 | 0.140 |
Why?
| | Spouses | 1 | 2018 | 104 | 0.130 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1550 | 0.130 |
Why?
| | Organ Transplantation | 1 | 2020 | 255 | 0.130 |
Why?
| | Diphenoxylate | 1 | 2016 | 5 | 0.130 |
Why?
| | Research Personnel | 1 | 2019 | 184 | 0.130 |
Why?
| | Antidiarrheals | 1 | 2016 | 14 | 0.130 |
Why?
| | Loperamide | 1 | 2016 | 12 | 0.130 |
Why?
| | Atropine | 1 | 2016 | 36 | 0.130 |
Why?
| | Nursing Assessment | 1 | 2017 | 58 | 0.130 |
Why?
| | Periodicals as Topic | 1 | 2019 | 213 | 0.130 |
Why?
| | Pressure Ulcer | 1 | 2017 | 46 | 0.130 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 284 | 0.130 |
Why?
| | Cause of Death | 1 | 2018 | 426 | 0.130 |
Why?
| | Terminally Ill | 1 | 2016 | 37 | 0.130 |
Why?
| | Patient Care Management | 1 | 2016 | 55 | 0.130 |
Why?
| | Voltage-Gated Sodium Channel Blockers | 1 | 2016 | 6 | 0.130 |
Why?
| | Follow-Up Studies | 6 | 2024 | 5165 | 0.130 |
Why?
| | Chromatography, Gas | 1 | 2016 | 33 | 0.130 |
Why?
| | Atrial Fibrillation | 1 | 2021 | 377 | 0.130 |
Why?
| | Consumer Health Information | 1 | 2016 | 49 | 0.120 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2016 | 55 | 0.120 |
Why?
| | Gastrointestinal Agents | 1 | 2016 | 66 | 0.120 |
Why?
| | Defibrillators, Implantable | 2 | 2016 | 304 | 0.120 |
Why?
| | Advanced Practice Nursing | 1 | 2016 | 38 | 0.120 |
Why?
| | Prosthesis Design | 2 | 2016 | 332 | 0.120 |
Why?
| | Truth Disclosure | 1 | 2016 | 50 | 0.120 |
Why?
| | Mortality | 1 | 2018 | 360 | 0.120 |
Why?
| | Health Policy | 2 | 2020 | 396 | 0.120 |
Why?
| | Canada | 1 | 2017 | 412 | 0.120 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 328 | 0.120 |
Why?
| | Hospices | 1 | 2016 | 88 | 0.120 |
Why?
| | Drug Combinations | 1 | 2016 | 347 | 0.120 |
Why?
| | Social Security | 1 | 2015 | 5 | 0.120 |
Why?
| | Medical Indigency | 1 | 2015 | 12 | 0.120 |
Why?
| | Sex Distribution | 1 | 2016 | 380 | 0.120 |
Why?
| | Diagnosis-Related Groups | 1 | 2015 | 31 | 0.120 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 196 | 0.120 |
Why?
| | Uncertainty | 1 | 2016 | 130 | 0.120 |
Why?
| | Referral and Consultation | 1 | 2021 | 799 | 0.120 |
Why?
| | Patient Care Planning | 1 | 2016 | 151 | 0.120 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3316 | 0.110 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 229 | 0.110 |
Why?
| | Patient Selection | 1 | 2019 | 692 | 0.110 |
Why?
| | Multimedia | 1 | 2014 | 12 | 0.110 |
Why?
| | Factor X | 1 | 2014 | 27 | 0.110 |
Why?
| | Workload | 1 | 2016 | 163 | 0.110 |
Why?
| | Fee-for-Service Plans | 1 | 2015 | 87 | 0.110 |
Why?
| | Health Care Costs | 1 | 2018 | 418 | 0.110 |
Why?
| | Nurse's Role | 1 | 2016 | 167 | 0.110 |
Why?
| | Assisted Circulation | 1 | 2014 | 25 | 0.110 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 101 | 0.110 |
Why?
| | Central Nervous System Stimulants | 1 | 2016 | 176 | 0.110 |
Why?
| | Treatment Refusal | 1 | 2015 | 96 | 0.110 |
Why?
| | Family Relations | 1 | 2015 | 91 | 0.110 |
Why?
| | Needs Assessment | 1 | 2016 | 381 | 0.110 |
Why?
| | Disease Progression | 2 | 2025 | 2741 | 0.100 |
Why?
| | Patient Discharge | 2 | 2022 | 909 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1049 | 0.100 |
Why?
| | Sex Factors | 2 | 2016 | 2054 | 0.100 |
Why?
| | Risk | 1 | 2016 | 913 | 0.100 |
Why?
| | Population Surveillance | 1 | 2017 | 480 | 0.100 |
Why?
| | Prognosis | 5 | 2024 | 4024 | 0.100 |
Why?
| | Cooperative Behavior | 1 | 2016 | 459 | 0.100 |
Why?
| | Length of Stay | 2 | 2017 | 1235 | 0.100 |
Why?
| | Heparin | 1 | 2014 | 262 | 0.100 |
Why?
| | Mass Screening | 1 | 2021 | 1287 | 0.100 |
Why?
| | Antibodies | 1 | 2014 | 408 | 0.090 |
Why?
| | Cohort Studies | 1 | 2023 | 5736 | 0.090 |
Why?
| | Pain Management | 1 | 2016 | 382 | 0.090 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 566 | 0.090 |
Why?
| | Program Evaluation | 1 | 2016 | 913 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2864 | 0.090 |
Why?
| | Acute Disease | 1 | 2014 | 1011 | 0.090 |
Why?
| | Immunosuppressive Agents | 1 | 2016 | 868 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1315 | 0.090 |
Why?
| | Pilot Projects | 1 | 2016 | 1763 | 0.090 |
Why?
| | Health Behavior | 1 | 2016 | 776 | 0.080 |
Why?
| | Time Factors | 4 | 2024 | 6885 | 0.080 |
Why?
| | Motivation | 1 | 2015 | 589 | 0.080 |
Why?
| | Frail Elderly | 2 | 2024 | 130 | 0.080 |
Why?
| | Internet | 1 | 2014 | 674 | 0.080 |
Why?
| | Prevalence | 1 | 2016 | 2746 | 0.080 |
Why?
| | Comorbidity | 3 | 2020 | 1656 | 0.080 |
Why?
| | Attitude of Health Personnel | 1 | 2016 | 1159 | 0.070 |
Why?
| | Incidence | 1 | 2014 | 2836 | 0.070 |
Why?
| | Bayes Theorem | 2 | 2019 | 413 | 0.060 |
Why?
| | Colorado | 3 | 2025 | 4532 | 0.060 |
Why?
| | Academic Medical Centers | 2 | 2020 | 512 | 0.060 |
Why?
| | Disease Management | 2 | 2022 | 620 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2706 | 0.060 |
Why?
| | Postoperative Complications | 3 | 2024 | 2738 | 0.050 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5537 | 0.050 |
Why?
| | Benzodiazepines | 1 | 2025 | 154 | 0.050 |
Why?
| | Michigan | 1 | 2024 | 124 | 0.050 |
Why?
| | Shock, Cardiogenic | 1 | 2024 | 60 | 0.050 |
Why?
| | Congresses as Topic | 1 | 2025 | 230 | 0.050 |
Why?
| | Cannabinoids | 1 | 2025 | 172 | 0.050 |
Why?
| | Young Adult | 2 | 2016 | 13341 | 0.050 |
Why?
| | Information Systems | 1 | 2023 | 61 | 0.050 |
Why?
| | Comprehension | 1 | 2024 | 175 | 0.050 |
Why?
| | Patient Care | 1 | 2023 | 114 | 0.050 |
Why?
| | Death | 1 | 2022 | 124 | 0.050 |
Why?
| | Self Care | 1 | 2024 | 383 | 0.040 |
Why?
| | Consensus | 1 | 2024 | 679 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 213 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 32 | 0.040 |
Why?
| | Role | 1 | 2020 | 30 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2024 | 683 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3273 | 0.040 |
Why?
| | Hospitals, Community | 1 | 2020 | 56 | 0.040 |
Why?
| | Pharmacogenomic Testing | 1 | 2020 | 60 | 0.040 |
Why?
| | Thromboembolism | 1 | 2021 | 118 | 0.040 |
Why?
| | Social Responsibility | 1 | 2020 | 51 | 0.040 |
Why?
| | Income | 1 | 2020 | 204 | 0.040 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 170 | 0.040 |
Why?
| | Contraindications, Procedure | 1 | 2019 | 12 | 0.040 |
Why?
| | Contracts | 1 | 2019 | 12 | 0.040 |
Why?
| | Visual Analog Scale | 1 | 2019 | 35 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2020 | 165 | 0.040 |
Why?
| | Self Efficacy | 1 | 2022 | 400 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 315 | 0.040 |
Why?
| | International Cooperation | 1 | 2019 | 204 | 0.040 |
Why?
| | Survival | 1 | 2018 | 39 | 0.040 |
Why?
| | Administration, Oral | 1 | 2021 | 790 | 0.040 |
Why?
| | Walk Test | 1 | 2018 | 78 | 0.030 |
Why?
| | Health Status | 1 | 2023 | 821 | 0.030 |
Why?
| | Equipment Design | 1 | 2019 | 520 | 0.030 |
Why?
| | Viral Load | 1 | 2019 | 501 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 364 | 0.030 |
Why?
| | ROC Curve | 1 | 2019 | 568 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 415 | 0.030 |
Why?
| | Intraoperative Care | 1 | 2017 | 63 | 0.030 |
Why?
| | Adolescent | 1 | 2016 | 21561 | 0.030 |
Why?
| | Health Surveys | 1 | 2019 | 521 | 0.030 |
Why?
| | Social Determinants of Health | 1 | 2020 | 265 | 0.030 |
Why?
| | Nurses | 1 | 2019 | 187 | 0.030 |
Why?
| | Hemorrhage | 1 | 2021 | 732 | 0.030 |
Why?
| | Postoperative Care | 1 | 2017 | 274 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1497 | 0.030 |
Why?
| | Video Recording | 1 | 2016 | 180 | 0.030 |
Why?
| | Life Change Events | 1 | 2016 | 152 | 0.030 |
Why?
| | Societies, Medical | 1 | 2019 | 839 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 804 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1036 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2018 | 575 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2019 | 766 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1313 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1404 | 0.030 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 621 | 0.020 |
Why?
| | Stroke | 1 | 2021 | 1138 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1722 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2016 | 654 | 0.020 |
Why?
| | Telemedicine | 1 | 2020 | 867 | 0.020 |
Why?
| | Body Mass Index | 1 | 2019 | 2388 | 0.020 |
Why?
| | Anxiety | 1 | 2016 | 1069 | 0.020 |
Why?
| | Cognition | 1 | 2016 | 1179 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 2019 | 1924 | 0.020 |
Why?
| | Child | 1 | 2022 | 21906 | 0.010 |
Why?
|
|
McIlvennan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|